Products

What will AGI do for Bornaprine?

This classification denotes an antimuscarinic agent with the molecular formula C21H31NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9M363FGA7J, chemically known as 2-phenylbicyclo(2.2.1)heptane-2-carboxylic acid, 3-(diethylamino)propyl ester but generally known as bornaprine, which bears US NIH Compound Identifier 30160. European Medicines Agency schedules Bornaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05874MIG. The term BORNAPRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules bornaprine in its Anatomical Therapeutic Chemical (ATC) Classification. BORNAPRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bornaprine under HS 29221980 and SITC 51461. As of Q4 2014, BORNAPRINE remains the US FDA Preferred Term for this commodity. Bornaprine bears US NLM identifiers UMLS ID C0053947 and NCI Concept Code C90742. SMILES: O(C(=O)C1(C2CC(C1)CC2)C1CCCCC1)CCCN(CC)CC.